LivaNova PLC (NASDAQ:LIVN)’s share price traded up 5% during trading on Monday . The company traded as high as $54.68 and last traded at $54.65, with a volume of 595,112 shares traded. The stock had previously closed at $52.05.

Separately, Piper Jaffray Cos. reaffirmed an “overweight” rating and set a $59.00 price objective (down from $61.00) on shares of LivaNova PLC in a report on Thursday, July 7th. Five research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $66.25.

The stock’s 50-day moving average is $50.25 and its 200 day moving average is $52.60. The stock’s market capitalization is $2.66 billion.

In related news, Director Hugh M. Morrison sold 3,600 shares of the business’s stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $48.00, for a total transaction of $172,800.00. Following the transaction, the director now directly owns 5,215 shares in the company, valued at $250,320. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Daniel Jeffrey Moore sold 1,000 shares of the business’s stock in a transaction on Tuesday, May 24th. The stock was sold at an average price of $50.07, for a total transaction of $50,070.00. Following the transaction, the director now owns 64,137 shares in the company, valued at $3,211,339.59. The disclosure for this sale can be found here.

Other institutional investors have recently modified their holdings of the company. Wells Fargo & Company MN purchased a new position in shares of LivaNova PLC during the fourth quarter worth $30,246,000. Schroder Investment Management Group bought a new position in LivaNova PLC during the fourth quarter valued at approximately $22,818,000. Principal Financial Group Inc. bought a new position in LivaNova PLC during the fourth quarter valued at approximately $7,987,000. KBC Group NV bought a new position in LivaNova PLC during the fourth quarter valued at approximately $4,610,000. Finally, Nicholas Co. Inc. WI bought a new position in LivaNova PLC during the fourth quarter valued at approximately $4,034,000.

LivaNova PLC is a United Kingdom-based medical technology company. The Company focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company operates under three business units: Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. The Company provides solutions for patients, healthcare professionals and healthcare systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.